165 related articles for article (PubMed ID: 18648740)
1. Mutation assay of the novel gene DOG1 in gastrointestinal stromal tumors (GISTs).
Miwa S; Nakajima T; Murai Y; Takano Y; Sugiyama T
J Gastroenterol; 2008; 43(7):531-7. PubMed ID: 18648740
[TBL] [Abstract][Full Text] [Related]
2. PDGFRA and KIT Mutation Status and Its Association With Clinicopathological Properties, Including DOG1.
Baskin Y; Kocal GC; Kucukzeybek BB; Akbarpour M; Kayacik N; Sagol O; Ellidokuz H; Oztop I
Oncol Res; 2016; 24(1):41-53. PubMed ID: 27178821
[TBL] [Abstract][Full Text] [Related]
3. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status.
West RB; Corless CL; Chen X; Rubin BP; Subramanian S; Montgomery K; Zhu S; Ball CA; Nielsen TO; Patel R; Goldblum JR; Brown PO; Heinrich MC; van de Rijn M
Am J Pathol; 2004 Jul; 165(1):107-13. PubMed ID: 15215166
[TBL] [Abstract][Full Text] [Related]
4. DOG1 and PKC-θ are useful in the diagnosis of KIT-negative gastrointestinal stromal tumors.
Kang GH; Srivastava A; Kim YE; Park HJ; Park CK; Sohn TS; Kim S; Kang DY; Kim KM
Mod Pathol; 2011 Jun; 24(6):866-75. PubMed ID: 21358619
[TBL] [Abstract][Full Text] [Related]
5. Presence of PDGFRA and DOG1 mutations in gastrointestinal stromal tumors among Chinese population.
Li J; Zhang H; Lu Y; Chen Z; Su K
Int J Clin Exp Pathol; 2015; 8(5):5721-6. PubMed ID: 26191287
[TBL] [Abstract][Full Text] [Related]
6. Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations.
Rizzo FM; Palmirotta R; Marzullo A; Resta N; Cives M; Tucci M; Silvestris F
BMC Cancer; 2016 Feb; 16():87. PubMed ID: 26867653
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes.
Liegl B; Hornick JL; Corless CL; Fletcher CD
Am J Surg Pathol; 2009 Mar; 33(3):437-46. PubMed ID: 19011564
[TBL] [Abstract][Full Text] [Related]
8. Expression of DOG1, CD117 and PDGFRA in gastrointestinal stromal tumors and correlations with clinicopathology.
Sui XL; Wang H; Sun XW
Asian Pac J Cancer Prev; 2012; 13(4):1389-93. PubMed ID: 22799337
[TBL] [Abstract][Full Text] [Related]
9. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.
Miettinen M; Wang ZF; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1401-8. PubMed ID: 19606013
[TBL] [Abstract][Full Text] [Related]
10. DOG1 regulates growth and IGFBP5 in gastrointestinal stromal tumors.
Simon S; Grabellus F; Ferrera L; Galietta L; Schwindenhammer B; Mühlenberg T; Taeger G; Eilers G; Treckmann J; Breitenbuecher F; Schuler M; Taguchi T; Fletcher JA; Bauer S
Cancer Res; 2013 Jun; 73(12):3661-70. PubMed ID: 23576565
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal stromal tumors (GISTs): CD117, DOG-1 and PKCθ expression. Is there any advantage in using several markers?
Ríos-Moreno MJ; Jaramillo S; Pereira Gallardo S; Vallejo A; Mora M; García-Escudero A; Amérigo J; González-Cámpora R
Pathol Res Pract; 2012 Feb; 208(2):74-81. PubMed ID: 22197035
[TBL] [Abstract][Full Text] [Related]
12. [Status and clinical implication of c-kit and PDGFRA mutations in 165 cases of gastrointestinal stromal tumor (GIST)].
He HY; Fang WG; Zhong HH; Li Y; Zheng J; Du J; Heng WJ; Wu BQ
Zhonghua Bing Li Xue Za Zhi; 2006 May; 35(5):262-6. PubMed ID: 16776995
[TBL] [Abstract][Full Text] [Related]
13. A Duodenal SDH-Deficient Gastrointestinal Stromal Tumor in a Patient With a Germline SDHB Mutation.
Elston MS; Sehgal S; Dray M; Phillips E; Conaglen JV; Clifton-Bligh RJ; Gill AJ
J Clin Endocrinol Metab; 2017 May; 102(5):1447-1450. PubMed ID: 28324028
[TBL] [Abstract][Full Text] [Related]
14. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor.
Zheng S; Chen LR; Wang HJ; Chen SZ
Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathologic features and immunophenotypes of CD117-negative gastrointestinal stromal tumor].
Shi JL; Chang XY; Chen J
Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):310-4. PubMed ID: 21756824
[TBL] [Abstract][Full Text] [Related]
16. DOG1 is useful for diagnosis of KIT-negative gastrointestinal stromal tumor of stomach.
Wada T; Tanabe S; Ishido K; Higuchi K; Sasaki T; Katada C; Azuma M; Naruke A; Kim M; Koizumi W; Mikami T
World J Gastroenterol; 2013 Dec; 19(47):9133-6. PubMed ID: 24379641
[TBL] [Abstract][Full Text] [Related]
17. A KIT-negative, DOG1-positive epithelioid GIST of the stomach harboring a novel PDGFRA exon 14 single nucleotide deletion.
Rizzardi C; Marzinotto S; Avellini C; Melato M; Mariuzzi L
Anticancer Res; 2012 May; 32(5):1775-8. PubMed ID: 22593460
[TBL] [Abstract][Full Text] [Related]
18. C-KIT and PDGFRA zygosity in gastrointestinal stromal tumors: Correlation with tumor site, tumor size, exon, and CD117 immunohistochemistry.
Wallander ML; Willmore-Payne C; Layfield LJ
Appl Immunohistochem Mol Morphol; 2011 Jan; 19(1):21-7. PubMed ID: 20823768
[TBL] [Abstract][Full Text] [Related]
19. Strong PDGFRA positivity is seen in GISTs but not in other intra-abdominal mesenchymal tumors: Immunohistochemical and mutational analyses.
Peterson MR; Piao Z; Weidner N; Yi ES
Appl Immunohistochem Mol Morphol; 2006 Dec; 14(4):390-6. PubMed ID: 17122634
[TBL] [Abstract][Full Text] [Related]
20. KIT-negative gastrointestinal stromal tumor of the abdominal soft tissue: a clinicopathologic and genetic study of 10 cases.
Yamamoto H; Kojima A; Nagata S; Tomita Y; Takahashi S; Oda Y
Am J Surg Pathol; 2011 Sep; 35(9):1287-95. PubMed ID: 21836495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
